136 related articles for article (PubMed ID: 19874446)
1. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer.
Koo JH; Leong RW
J Gastroenterol Hepatol; 2010 Jan; 25(1):33-42. PubMed ID: 19874446
[TBL] [Abstract][Full Text] [Related]
2. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
3. The implications of colorectal cancer molecular biology in clinical practice.
Kargozaran H; Kahlenberg M; Khatri VP
Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic outcomes of colorectal cancer in a multi-ethnic population.
Koo JH; Kin S; Wong C; Jalaludin B; Kneebone A; Connor SJ; Leong RW
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1016-21. PubMed ID: 18558515
[TBL] [Abstract][Full Text] [Related]
5. Is gender related to the stage of colorectal cancer at initial presentation in young patients?
Fancher TT; Palesty JA; Rashidi L; Dudrick SJ
J Surg Res; 2011 Jan; 165(1):15-8. PubMed ID: 21074787
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survival.
Stefanidis D; Pollock BH; Miranda J; Wong A; Sharkey FE; Rousseau DL; Thomas CR; Kahlenberg MS
Am J Clin Oncol; 2006 Apr; 29(2):123-6. PubMed ID: 16601428
[TBL] [Abstract][Full Text] [Related]
7. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
Clin Cancer Res; 2001 May; 7(5):1343-9. PubMed ID: 11350904
[TBL] [Abstract][Full Text] [Related]
8. Correlation between family history of colorectal cancer and pathological and clinical features of the disease.
Aste H; Picasso M; Allegretti A; Conio M
Cancer Detect Prev; 1994; 18(5):343-8. PubMed ID: 7812980
[TBL] [Abstract][Full Text] [Related]
9. Are there any differences in colorectal cancer between young and elderly patients?
Frizis H; Papadopoulos A; Akritidis G; Frizis HR; Hatzitheoharis G
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s147-8. PubMed ID: 15655603
[TBL] [Abstract][Full Text] [Related]
10. Stage of disease at time of attendance of patients with colorectal cancer at the Department of Surgery of the General Hospital of Edessa.
Economou A; Saliangas K; Nikoloudis N; Andreadis E; Siminou S; Zacharopoulos Z; Politidou E; Chrissidis T
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s196-8. PubMed ID: 15655621
[TBL] [Abstract][Full Text] [Related]
11. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
[TBL] [Abstract][Full Text] [Related]
12. Family history and age at initiation of colorectal cancer screening.
Brenner H; Hoffmeister M; Haug U
Am J Gastroenterol; 2008 Sep; 103(9):2326-31. PubMed ID: 18702651
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer among Yemeni patients. Characteristics and trends.
Basaleem HO; Al-Sakkaf KA
Saudi Med J; 2004 Aug; 25(8):1002-5. PubMed ID: 15322587
[TBL] [Abstract][Full Text] [Related]
14. [Detection of microsatellite instability in colorectal cancer by fluorescence multiplex polymerase chain reaction and its clinical value].
Jin HY; Lai RS; Ding YJ; Xie L; Yang BL; Liu F; Ding SQ; Ge YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):217-20. PubMed ID: 17520377
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
16. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
[TBL] [Abstract][Full Text] [Related]
17. Screening of colorectal cancer.
Winawer SJ
Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and survival after colorectal cancer diagnosis.
Chan JA; Meyerhardt JA; Chan AT; Giovannucci EL; Colditz GA; Fuchs CS
J Clin Oncol; 2006 Dec; 24(36):5680-6. PubMed ID: 17179103
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer in patients over 70 years of age: determinants of outcome.
Basdanis G; Papadopoulos VN; Michalopoulos A; Fahantidis E; Apostolidis S; Berovalis P; Zatagias A; Karamanlis E
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s112-5. PubMed ID: 15655591
[TBL] [Abstract][Full Text] [Related]
20. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
